ORLANDO, Fla., June 26, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from ...
Encapsulating human stem-cell-derived beta cells in microcapsules made with an immune-cell-repelling protein restored glucose metabolism in diabetic mice and protected the cells from immune system ...
New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results